pharma · Renal Transplantation · Rheumatoid Arthritis (RA)
Astellas Pharma
Astellas Pharma Inc
Astellas Pharma trial registry — 20 ClinicalTrials.gov studies with program phase, status, and indication context.
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP HQ
12,378 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP
- Employees
- 12,378
- Programs
- 20
- Drugs
- 12
- Patents
- 25
Astellas Pharma clinical trials
Registry index of 20 ClinicalTrials.gov studies linked to Astellas Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Astellas Pharma trial registry — 20 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Astellas Pharma.
-
tacrolimus — Phase 3
Clinical update -
Tacrolimus capsule — Phase 3
Clinical update -
Tacrolimus — Phase 2
Clinical update -
ADVAGRAF — Approved
Clinical update -
ASP8825 — Phase 3
Clinical update -
Fezolinetant — Phase 3
Clinical update -
Isavuconazole — Phase 3
Clinical update -
Mirabegron — Phase 3
Clinical update